Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Giraudo Bryan
Over the trailing 90 days, Giraudo Bryan (Director at Protagonist Therapeutics, Inc) traded $6.2M of stock (net selling $5.7M) in PTGX, per 8 SEC Form 4 transactions.
- Role
- Director
- Companies
- PTGX
- Window
- Trailing 90 days · 8 transactions · CIK 1740847
- Net activity
- −$5.7M ($239K bought · $5.9M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | 8 | $239K | $5.9M | −$5.7M |
Transactions (8)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-08 | PTGX | Sell | 6.0K | $600K | Open market or private sale |
| 2026-05-08 | PTGX | Sell | 5.1K | $513K | Open market or private sale |
| 2026-05-07 | PTGX | Sell | 24.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-07 | PTGX | Sell | 12.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-07 | PTGX | Sell | 36.0K | $3.6M | Open market or private sale |
| 2026-05-07 | PTGX | Buy | 12.0K | $84K | Exercise or conversion of derivative security |
| 2026-05-07 | PTGX | Buy | 24.0K | $155K | Exercise or conversion of derivative security |
| 2026-05-07 | PTGX | Sell | 12.0K | $1.2M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Giraudo's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.